Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic strategies after first treatment failure in HIV-1 infection
2009-011816-39Phase 4Terminated
- Sponsor
- Imperial College London
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of etravirine, darunavir, emtricitabine + tenofovir disoproxil and ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Imperial College London. Primary endpoint: Change in adipose tissue (peripheral and central) by DEXA. Started Mar 2010; status: terminated.
02
Drugs
etravirinedarunaviremtricitabine + tenofovir disoproxilritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-011816-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011816-39.